Repligen
RGEN
#2650
Rank
S$8.46 B
Marketcap
S$150.03
Share price
3.10%
Change (1 day)
-21.45%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): S$0.10 Billion

According to Repligen 's latest financial reports the company's current earnings are S$0.73 Billion. , an increase over its 2024 earnings that were of -S$8.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 S$0.10 B-1430.84%
2024 -S$8.05 Million-113.01%
2023 S$61.81 M-78.01%
2022 S$0.28 B33.37%
2021 S$0.21 B131.52%
2020 S$91.02 M101.31%
2019 S$45.21 M25.93%
2018 S$35.9 M105.61%
2017 S$17.46 M-11.46%
2016 S$19.72 M14.91%
2015 S$17.16 M20.26%
2014 S$14.27 M-51.49%
2013 S$29.42 M90.98%
2012 S$15.4 M
2010 S$0.22 M-103.81%
2009 -S$5.86 Million-223.84%
2008 S$4.72 M
2006 -S$3.18 Million229.64%
2005 -S$0.97 Million-89.16%
2004 -S$8.89 Million-16.86%
2003 -S$10.69 Million88.72%
2002 -S$5.67 Million-27.88%
2001 -S$7.86 Million-1.74%
2000 -S$8 Million85.93%
1999 -S$4.3 Million159.16%
1998 -S$1.66 Million85.71%
1997 -S$0.9 Million-70.83%
1996 -S$3.07 Million-72.41%
1995 -S$11.1 Million-60.63%
1994 -S$28.2 Million45.39%
1993 -S$19.4 Million39.45%
1992 -S$13.91 Million-32.3%
1991 -S$20.55 Million6.62%
1990 -S$19.27 Million1577.78%
1989 -S$1.15 Million-57.14%
1988 -S$2.68 Million-362.5%
1987 S$1.02 M-130.77%
1986 -S$3.32 Million136.36%
1985 -S$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.00 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$9.32 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$13.83 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$11.90 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.14 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.47 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.81 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.15 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.61 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-S$0.13 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA